SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of unusually large options trading activity on Friday. Investors purchased 83,179 put options on the stock. This represents an increase of approximately 50% compared to the typical daily volume of 55,585 put options.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $123.43 on Friday. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $125.87. The firm has a market capitalization of $7.49 billion, a P/E ratio of 11.47 and a beta of 0.93. The company has a 50-day simple moving average of $115.20 and a 200-day simple moving average of $98.59.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its stake in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Greenwoods Asset Management Hong Kong Ltd. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at about $55,613,000. Ameriprise Financial Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the period. Meitav Investment House Ltd. increased its position in SPDR S&P Biotech ETF by 2,199.6% during the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock worth $33,229,000 after buying an additional 383,040 shares during the period. Finally, Strs Ohio bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $27,801,000.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.